Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15

Glucose-dependent insulinotropic peptide (GIP) is an incretin hormone produced in the gastrointestinal tract that stimulates glucose dependent insulin secretion. Impaired incretin response has been documented in diabetic patients and was mainly related to the inability of the pancreatic beta cells t...

Full description

Saved in:
Bibliographic Details
Main Authors: Alessandra Puddu, Roberta Sanguineti, Fabrizio Montecucco, Giorgio Luciano Viviani
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2015/326359
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558183917289472
author Alessandra Puddu
Roberta Sanguineti
Fabrizio Montecucco
Giorgio Luciano Viviani
author_facet Alessandra Puddu
Roberta Sanguineti
Fabrizio Montecucco
Giorgio Luciano Viviani
author_sort Alessandra Puddu
collection DOAJ
description Glucose-dependent insulinotropic peptide (GIP) is an incretin hormone produced in the gastrointestinal tract that stimulates glucose dependent insulin secretion. Impaired incretin response has been documented in diabetic patients and was mainly related to the inability of the pancreatic beta cells to secrete insulin in response to GIP. Advanced Glycation End Products (AGEs) have been shown to play an important role in pancreatic beta cell dysfunction. The aim of this study is to investigate whether the exposure to AGEs can induce GIP resistance in the pancreatic beta cell line HIT-T15. Cells were cultured for 5 days in low (CTR) or high glucose (HG) concentration in the presence of AGEs (GS) to evaluate the expression of GIP receptor (GIPR), the intracellular signaling activated by GIP, and secretion of insulin in response to GIP. The results showed that incubation with GS alone altered intracellular GIP signaling and decreased insulin secretion as compared to CTR. GS in combination with HG reduced the expression of GIPR and PI3K and abrogated GIP-induced AKT phosphorylation and GIP-stimulated insulin secretion. In conclusion, we showed that treatment with GS is associated with the loss of the insulinotropic effect of GIP in hyperglycemic conditions.
format Article
id doaj-art-74562f83965546fc9f33a0875122d71d
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-74562f83965546fc9f33a0875122d71d2025-02-03T01:33:00ZengWileyJournal of Diabetes Research2314-67452314-67532015-01-01201510.1155/2015/326359326359Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15Alessandra Puddu0Roberta Sanguineti1Fabrizio Montecucco2Giorgio Luciano Viviani3Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 16143 Genoa, ItalyDepartment of Internal Medicine, University of Genoa, Viale Benedetto XV, 16143 Genoa, ItalyDepartment of Internal Medicine, University of Genoa, Viale Benedetto XV, 16143 Genoa, ItalyDepartment of Internal Medicine, University of Genoa, Viale Benedetto XV, 16143 Genoa, ItalyGlucose-dependent insulinotropic peptide (GIP) is an incretin hormone produced in the gastrointestinal tract that stimulates glucose dependent insulin secretion. Impaired incretin response has been documented in diabetic patients and was mainly related to the inability of the pancreatic beta cells to secrete insulin in response to GIP. Advanced Glycation End Products (AGEs) have been shown to play an important role in pancreatic beta cell dysfunction. The aim of this study is to investigate whether the exposure to AGEs can induce GIP resistance in the pancreatic beta cell line HIT-T15. Cells were cultured for 5 days in low (CTR) or high glucose (HG) concentration in the presence of AGEs (GS) to evaluate the expression of GIP receptor (GIPR), the intracellular signaling activated by GIP, and secretion of insulin in response to GIP. The results showed that incubation with GS alone altered intracellular GIP signaling and decreased insulin secretion as compared to CTR. GS in combination with HG reduced the expression of GIPR and PI3K and abrogated GIP-induced AKT phosphorylation and GIP-stimulated insulin secretion. In conclusion, we showed that treatment with GS is associated with the loss of the insulinotropic effect of GIP in hyperglycemic conditions.http://dx.doi.org/10.1155/2015/326359
spellingShingle Alessandra Puddu
Roberta Sanguineti
Fabrizio Montecucco
Giorgio Luciano Viviani
Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15
Journal of Diabetes Research
title Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15
title_full Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15
title_fullStr Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15
title_full_unstemmed Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15
title_short Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15
title_sort effects of high glucose levels and glycated serum on gip responsiveness in the pancreatic beta cell line hit t15
url http://dx.doi.org/10.1155/2015/326359
work_keys_str_mv AT alessandrapuddu effectsofhighglucoselevelsandglycatedserumongipresponsivenessinthepancreaticbetacelllinehitt15
AT robertasanguineti effectsofhighglucoselevelsandglycatedserumongipresponsivenessinthepancreaticbetacelllinehitt15
AT fabriziomontecucco effectsofhighglucoselevelsandglycatedserumongipresponsivenessinthepancreaticbetacelllinehitt15
AT giorgiolucianoviviani effectsofhighglucoselevelsandglycatedserumongipresponsivenessinthepancreaticbetacelllinehitt15